Cargando…
The androgen receptor can signal through Wnt/β-Catenin in prostate cancer cells as an adaptation mechanism to castration levels of androgens
BACKGROUND: A crucial event in Prostate Cancer progression is the conversion from a hormone-sensitive to a hormone-refractory disease state. Correlating with this transition, androgen receptor (AR) amplification and mutations are often observed in patients failing hormonal ablation therapies. β-Cate...
Autores principales: | Schweizer, Liang, Rizzo, Cheryl A, Spires, Thomas E, Platero, J Suso, Wu, Qiuyan, Lin, Tai-An, Gottardis, Marco M, Attar, Ricardo M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246119/ https://www.ncbi.nlm.nih.gov/pubmed/18218096 http://dx.doi.org/10.1186/1471-2121-9-4 |
Ejemplares similares
-
Persistent androgen receptor addiction in castration-resistant prostate cancer
por: Schweizer, Michael T., et al.
Publicado: (2015) -
Interplay Between SOX9, Wnt/β-Catenin and Androgen Receptor Signaling in Castration-Resistant Prostate Cancer
por: Khurana, Namrata, et al.
Publicado: (2019) -
Androgens as therapy for androgen receptor-positive castration-resistant prostate cancer
por: Chuu, Chih-Pin, et al.
Publicado: (2011) -
Adaptive responses of androgen receptor signaling in castration-resistant prostate cancer
por: Perner, Sven, et al.
Publicado: (2015) -
Clinical Significance of Wnt/β-Catenin Signalling and Androgen Receptor Expression in Prostate Cancer
por: Jung, Soo Jin, et al.
Publicado: (2013)